关于我们联系我们访客留言English中文版

业务咨询电话:010-84783288,028-81715678

新闻动态

电话:
010-84783288,028-81715678
传真:010-84783133
E-mail:ytjj@yuntaifund.com
地址:
广东:深圳市前海深港合作区前湾一路1号A栋201室
北京:北京朝阳区望京金辉大厦1201、1208室
四川:成都市青羊区东坡北三路齐力生活广场齐力商务港5楼          

当前位置:Home > 新闻动态 > 企业新闻
企业新闻
云泰基金被投企业动态:脊柱非融合术领先企业Empirical Spine公司进行B轮融资,预计2022年通过FDA/PMA(图文)

Yuntai Fund’s post-investment case study: Leading spinal non-fusion company Empirical Spine is raising B-round financing, the company is expected to pass the FDA/PMA in 2022.


Empirical Spine创始团队独创LimiFlex棘突张力带,于2009年获得欧盟CE认证。Empirical Spine公司总部位于美国加州,业务和研发团队遍布欧洲、美国、中国等地,公司核心研发团队来自美国斯坦福大学,在脊柱非融合术方面拥有很深的研究造诣。2017年,Empirical Spine公司进行了A轮融资,估值数百万美元,获得了来自全球各地知名家族基金和投资机构的数百万美元融资,云泰基金也参与其中。


The original LimiFlex spinous tension band was created by the founding team of Empirical Spine. The technology obtained CE mark in 2009. Headquartered in California, the company's business and R & D teams are located in Europe, the United States, and China. The company's core R & D team comes from Stanford University in the United States with deep R&D background in spinal non-fusion. In 2017, the company conducted A-round financing with valuation of millions of dollars. The company received millions of dollars of financing from well-known family trusts and investment institutions around the world, in which Yuntai fund also participated.

 

 

empirical.jpg

 

After three years of growth, the Empirical Spine is currently conducting IDE trial, laying a solid foundation for passing FDA / PMA two years later based on estimation. At present, the company is carrying out round B-financing, with a valuation of tens of millions of dollars. The company has already secure several investment agreements with multiple family trusts and private equity institutions.

电话:010-84783288 028-81715678 地址:北京朝阳区望京金辉大厦1201、1208室
粤ICP备19091196号
Power by:ewebdo.com